Biopharmaceutical company streamlines document exchange

Share this on social media:

Actelion Pharmaceuticals, a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, has selected IntraLinks Connect to streamline its documentation exchange during clinical trials. IntraLinks Connect, a cloud-based platform, will provide central clinical trial portals to facilitate the more secure, compliant auditable exchange of site feasibility, study start-up, study conduct and study close-out documentation.